Will Short Term Positive News Increase The Share Price Of Fennec Pharmaceuticals Inc. (FENC)?

Fennec Pharmaceuticals Inc. (FENC) has seen some recent action in the marketplace and its stock closed at $7.38 yesterday. People are starting to take interest of FENC as the stock traded as high as $7.91 and as low as $7.33 in the prior market session.

Fennec Pharmaceuticals Inc. (FENC) average trading volume is 388.54K. However, in the prior market session Fennec Pharmaceuticals Inc. (FENC) exchanged 129,351 shares. The 1st downside support level on FENC is $7.26 and the 1st upside resistance level on FENC is $10.17. FENC fifty day moving average is $6.72 and FENC two hundred day moving average is $7.32.

Fennec Pharmaceuticals Inc. (FENC) recent performance has been specified by the recent movement in FENC stock. FENC has performed 23.62% over the past month, FENC has performed -11.40% over the past quarter and FENC has shown 41.63% over the past 12 months. Fennec Pharmaceuticals Inc. (FENC) has a 12 month range of $4.65 to $10.67. Fennec Pharmaceuticals Inc. (FENC) is trading 58.71% from its 12 month low and -30.83% from its 12 month high. Fennec Pharmaceuticals Inc. (FENC) is showing a 6.64% short float showing the sum short in the float.

FENC has 23.39M shares outstanding and 21.01M shares in the float. Fennec Pharmaceuticals Inc. (FENC) at this time has a market cap of $185.90M and income of -14.10M. The EPS next quarter for FENC is -0.19 and forecasted EPS next year is 273.90%. The market cap of Fennec Pharmaceuticals Inc. (FENC) at $185.90M signifies how many People own shares of FENC and is calculated off the last price ($7.38) of FENC and the sum of shares outstanding (23.39M) with Fennec Pharmaceuticals Inc. (FENC).

Fennec Pharmaceuticals Inc. (FENC) has total cash (mrq) of 38.73M, total cash per share (mrq) of 1.53, . Fennec Pharmaceuticals Inc. (FENC) operational cash flow (ttm) is -10.69M, FENC leveraged free cash flow (ttm) is -5.34M.

FENC is trading 1.60% above (bullish) its SMA20, 16.41% above (bullish) its SMA50 and 4.63% above (bullish) its SMA200.

Related Articles

BioNTech (NASDAQ: BNTX) Inks Deal With InstaDeep To Develop Novel Immunotherapies

BioNTech SE (NASDAQ: BNTX) has signed a strategic partnership contract with InstaDeep Ltd. Both the companies are planning to use the latest technologies such...

iHeartMedia (NASDAQ: IHRT) Announces Partnership With Podimo

iHeartMedia, Inc. (NASDAQ: IHRT) has entered into a partnership with Podimo, a European Podcast platform. Both the companies inked an agreement to adapt and...

Ruhnn (NASDAQ: RUHN) Receives Going Private Proposal

Ruhnn Holding Limited's (NASDAQ: RUHN) boards of directors have got the preliminary non-binding offer letter from three founders of the firm. Founder Chao Shen,...

Get in Touch

19,000FansLike
35,222FollowersFollow
22,458FollowersFollow

Latest Posts

BioNTech (NASDAQ: BNTX) Inks Deal With InstaDeep To Develop Novel Immunotherapies

BioNTech SE (NASDAQ: BNTX) has signed a strategic partnership contract with InstaDeep Ltd. Both the companies are planning to use the latest technologies such...

iHeartMedia (NASDAQ: IHRT) Announces Partnership With Podimo

iHeartMedia, Inc. (NASDAQ: IHRT) has entered into a partnership with Podimo, a European Podcast platform. Both the companies inked an agreement to adapt and...

Ruhnn (NASDAQ: RUHN) Receives Going Private Proposal

Ruhnn Holding Limited's (NASDAQ: RUHN) boards of directors have got the preliminary non-binding offer letter from three founders of the firm. Founder Chao Shen,...

Moderna (NASDAQ: MRNA) Inks 160M COVID Vaccine Doses Supply Deal With EU

Moderna, Inc. (NASDAQ: MRNA) has secured a supply contract for up to 160 million doses of COVID-19 vaccine candidates from the European Union. Moderna...

Why Ayro (NASDAQ: AYRO) Stock Is Crashing Today?

Shares of Ayro Inc. (NASDAQ: AYRO) plummeted by 23.49% during the trading session on Tuesday. The firm has disclosed that it has completed the...